(Photo: iStock)

The Medicines and Health products Regulatory Agency (MHRA) on Tuesday (September 29) issued a class three medicines recall for AlfaD capsules of Theramex.

The recall follows a communication MHRA received from Theramex on an issue related to an error in the decommissioning of the drug batches.

“Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘EXPORT’, although there is no risk to product quality, any remaining stock should be quarantined and returned,” the MHRA has said.

Product details
AlfaD 0.25 microgram capsules PL 49876/0001

Batch Number Expiry Date Pack Size First Distributed
A04285 Apr 2022 30 15 Sep 2020

 

AlfaD 1 microgram capsules PL 49876/0003

Batch Number Expiry Date Pack Size First Distributed
106389 Aug 2022 30 15 Sep 2020

 

Community pharmacists have been advised to stop supplying the batches immediately and quarantine all remaining stock to return it to the concerned supplier using supplier’s approved process.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY